Why it matters: Without lasting behavior changes and healthy habits, many GLP-1 users ultimately end up back where they started
In four cancer types, the GLP-1 group was less likely to develop stage IV cancer: Lung cancer - 50% risk reduction Breast cancer - 43% risk reduction Liver cancer - 38% risk reduction Colorectal cancer - 31% risk reduction In the other three cancers - prostate, pancreatic and kidney - the GLP-1 group had fewer instances of stage IV disease, but the differences were not statistically significant
Studies have found elevated levels of autoantibodies targeting key receptors, such as ACE2 (the primary receptor for SARS-CoV-2), 2-adrenoceptors, muscarinic M2 receptors, angiotensin II AT1 receptors, and angiotensin 17 MAS receptors [73,74,75]
Efficacy Testing This product provides whitening power through a high dose of 1650mg, with a blood absorption rate of approximately 78%-80%